Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genome, Viral | 19 | 2021 | 109 | 2.860 |
Why?
|
| Hemorrhagic Fever, Ebola | 16 | 2019 | 29 | 2.650 |
Why?
|
| Viruses | 6 | 2023 | 36 | 2.530 |
Why?
|
| Ebolavirus | 15 | 2019 | 42 | 2.450 |
Why?
|
| Phylogeny | 17 | 2020 | 644 | 1.720 |
Why?
|
| Disease Outbreaks | 13 | 2023 | 155 | 1.160 |
Why?
|
| Antibodies, Viral | 6 | 2024 | 262 | 1.020 |
Why?
|
| Sequence Analysis, DNA | 10 | 2017 | 474 | 0.960 |
Why?
|
| Anthozoa | 3 | 2013 | 24 | 0.940 |
Why?
|
| Immunosorbents | 1 | 2022 | 1 | 0.870 |
Why?
|
| Peptide Library | 1 | 2022 | 25 | 0.860 |
Why?
|
| Onygenales | 1 | 2022 | 2 | 0.860 |
Why?
|
| Dermatomycoses | 1 | 2022 | 7 | 0.850 |
Why?
|
| Proteomics | 1 | 2022 | 325 | 0.730 |
Why?
|
| RNA, Viral | 8 | 2019 | 301 | 0.710 |
Why?
|
| Genetic Variation | 4 | 2016 | 387 | 0.660 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 68 | 0.660 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 76 | 0.660 |
Why?
|
| Communicable Disease Control | 1 | 2019 | 32 | 0.650 |
Why?
|
| Communicable Diseases | 1 | 2019 | 45 | 0.640 |
Why?
|
| Evolution, Molecular | 4 | 2020 | 268 | 0.630 |
Why?
|
| Dinoflagellida | 3 | 2014 | 8 | 0.580 |
Why?
|
| Colobus | 1 | 2016 | 1 | 0.570 |
Why?
|
| RNA Viruses | 1 | 2016 | 22 | 0.560 |
Why?
|
| Culicidae | 1 | 2016 | 24 | 0.560 |
Why?
|
| Animals | 29 | 2024 | 15081 | 0.530 |
Why?
|
| Genomics | 5 | 2019 | 223 | 0.510 |
Why?
|
| Selection, Genetic | 2 | 2017 | 54 | 0.480 |
Why?
|
| Symbiosis | 3 | 2014 | 43 | 0.480 |
Why?
|
| Orthobunyavirus | 1 | 2014 | 3 | 0.480 |
Why?
|
| Acclimatization | 2 | 2013 | 21 | 0.460 |
Why?
|
| Hot Temperature | 2 | 2014 | 128 | 0.440 |
Why?
|
| Liberia | 9 | 2019 | 13 | 0.430 |
Why?
|
| Simian immunodeficiency virus | 2 | 2024 | 59 | 0.430 |
Why?
|
| Genetic Speciation | 1 | 2012 | 9 | 0.420 |
Why?
|
| Mutation | 5 | 2024 | 1095 | 0.390 |
Why?
|
| Humans | 35 | 2024 | 37093 | 0.370 |
Why?
|
| Copepoda | 1 | 2009 | 5 | 0.350 |
Why?
|
| DNA | 2 | 2022 | 574 | 0.330 |
Why?
|
| Genotype | 4 | 2020 | 730 | 0.330 |
Why?
|
| Metagenomics | 2 | 2021 | 34 | 0.310 |
Why?
|
| Molecular Epidemiology | 5 | 2020 | 50 | 0.300 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 1568 | 0.300 |
Why?
|
| Host-Pathogen Interactions | 2 | 2019 | 186 | 0.300 |
Why?
|
| Genetics, Population | 2 | 2022 | 100 | 0.290 |
Why?
|
| Burkholderia | 2 | 2017 | 17 | 0.280 |
Why?
|
| Sequence Analysis, RNA | 5 | 2019 | 106 | 0.280 |
Why?
|
| Cluster Analysis | 3 | 2016 | 195 | 0.270 |
Why?
|
| Burkholderia pseudomallei | 2 | 2017 | 34 | 0.270 |
Why?
|
| Viral Envelope Proteins | 2 | 2017 | 82 | 0.270 |
Why?
|
| Virus Replication | 3 | 2024 | 278 | 0.270 |
Why?
|
| Antibody Formation | 2 | 2022 | 74 | 0.270 |
Why?
|
| Geography | 4 | 2020 | 96 | 0.270 |
Why?
|
| Antibodies, Monoclonal | 2 | 2019 | 290 | 0.260 |
Why?
|
| Moraxella | 2 | 2015 | 2 | 0.260 |
Why?
|
| Moraxellaceae Infections | 2 | 2015 | 2 | 0.260 |
Why?
|
| Monkey Diseases | 2 | 2015 | 6 | 0.260 |
Why?
|
| Phlebovirus | 2 | 2015 | 2 | 0.250 |
Why?
|
| Papio | 1 | 2024 | 22 | 0.240 |
Why?
|
| Semen | 4 | 2018 | 51 | 0.240 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2024 | 57 | 0.240 |
Why?
|
| Enterovirus D, Human | 1 | 2023 | 2 | 0.230 |
Why?
|
| Enterovirus Infections | 1 | 2023 | 4 | 0.230 |
Why?
|
| Aedes | 3 | 2019 | 34 | 0.230 |
Why?
|
| Chromosome Mapping | 1 | 2023 | 188 | 0.220 |
Why?
|
| Oligonucleotides | 1 | 2022 | 49 | 0.220 |
Why?
|
| Incidence | 3 | 2020 | 922 | 0.220 |
Why?
|
| Snakes | 1 | 2022 | 9 | 0.210 |
Why?
|
| Climate Change | 2 | 2013 | 35 | 0.210 |
Why?
|
| Antibodies | 1 | 2022 | 141 | 0.210 |
Why?
|
| Macaca mulatta | 3 | 2021 | 128 | 0.210 |
Why?
|
| Mammals | 1 | 2022 | 105 | 0.200 |
Why?
|
| Deoxyribonuclease I | 1 | 2021 | 25 | 0.200 |
Why?
|
| Proviruses | 1 | 2021 | 29 | 0.200 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2022 | 448 | 0.190 |
Why?
|
| Academies and Institutes | 2 | 2018 | 37 | 0.190 |
Why?
|
| Software | 2 | 2020 | 217 | 0.190 |
Why?
|
| Brucellosis, Bovine | 1 | 2020 | 2 | 0.180 |
Why?
|
| Brucella abortus | 1 | 2020 | 5 | 0.180 |
Why?
|
| Brucellosis | 1 | 2020 | 8 | 0.180 |
Why?
|
| Insect Vectors | 2 | 2017 | 25 | 0.180 |
Why?
|
| Arizona | 1 | 2020 | 100 | 0.180 |
Why?
|
| Antiviral Agents | 2 | 2019 | 157 | 0.180 |
Why?
|
| Lassa Fever | 1 | 2019 | 1 | 0.180 |
Why?
|
| Lassa virus | 1 | 2019 | 1 | 0.180 |
Why?
|
| Peptides | 1 | 2022 | 320 | 0.180 |
Why?
|
| DNA, Mitochondrial | 2 | 2012 | 175 | 0.170 |
Why?
|
| Survivors | 2 | 2018 | 136 | 0.170 |
Why?
|
| Turtles | 1 | 2019 | 28 | 0.170 |
Why?
|
| Sequence Homology | 2 | 2016 | 34 | 0.170 |
Why?
|
| Salmonella typhimurium | 1 | 2019 | 40 | 0.170 |
Why?
|
| Ebola Vaccines | 1 | 2019 | 8 | 0.170 |
Why?
|
| Viral Proteins | 1 | 2020 | 174 | 0.170 |
Why?
|
| Genome, Bacterial | 2 | 2017 | 114 | 0.170 |
Why?
|
| Macaca fascicularis | 2 | 2015 | 64 | 0.170 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2018 | 12 | 0.170 |
Why?
|
| Plasmids | 2 | 2021 | 246 | 0.160 |
Why?
|
| Adaptation, Physiological | 1 | 2019 | 109 | 0.160 |
Why?
|
| Virulence Factors | 2 | 2017 | 113 | 0.160 |
Why?
|
| Arenaviruses, New World | 1 | 2017 | 1 | 0.150 |
Why?
|
| Arenaviridae Infections | 1 | 2017 | 3 | 0.150 |
Why?
|
| DNA, Intergenic | 1 | 2017 | 10 | 0.150 |
Why?
|
| Sugar Acids | 1 | 2017 | 1 | 0.150 |
Why?
|
| Chikungunya virus | 1 | 2017 | 16 | 0.150 |
Why?
|
| Mutant Proteins | 1 | 2017 | 51 | 0.150 |
Why?
|
| Virus Internalization | 1 | 2017 | 28 | 0.150 |
Why?
|
| Kidney Diseases | 1 | 2019 | 167 | 0.150 |
Why?
|
| Vaccines, Attenuated | 1 | 2017 | 72 | 0.150 |
Why?
|
| Mutation, Missense | 1 | 2017 | 83 | 0.140 |
Why?
|
| Nairovirus | 1 | 2016 | 1 | 0.140 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2017 | 77 | 0.140 |
Why?
|
| Tularemia | 1 | 2017 | 114 | 0.140 |
Why?
|
| Poly U | 1 | 2015 | 2 | 0.140 |
Why?
|
| Primates | 1 | 2016 | 36 | 0.140 |
Why?
|
| Burkholderia mallei | 1 | 2015 | 6 | 0.140 |
Why?
|
| Francisella tularensis | 1 | 2017 | 115 | 0.130 |
Why?
|
| Immunization, Passive | 1 | 2015 | 19 | 0.130 |
Why?
|
| User-Computer Interface | 1 | 2015 | 62 | 0.130 |
Why?
|
| Immune Evasion | 1 | 2015 | 16 | 0.130 |
Why?
|
| Microscopy, Fluorescence | 1 | 2016 | 252 | 0.130 |
Why?
|
| Bunyaviridae Infections | 1 | 2015 | 5 | 0.130 |
Why?
|
| Sexually Transmitted Diseases, Viral | 1 | 2015 | 11 | 0.130 |
Why?
|
| Chemokines | 1 | 2015 | 97 | 0.130 |
Why?
|
| Fever | 1 | 2015 | 57 | 0.130 |
Why?
|
| Macaca | 1 | 2014 | 38 | 0.130 |
Why?
|
| United States | 2 | 2022 | 4223 | 0.120 |
Why?
|
| Computational Biology | 2 | 2015 | 293 | 0.120 |
Why?
|
| Phlebotomus Fever | 1 | 2013 | 1 | 0.120 |
Why?
|
| Hybridization, Genetic | 1 | 2012 | 14 | 0.100 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 540 | 0.100 |
Why?
|
| Statistics as Topic | 1 | 2012 | 117 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2015 | 1015 | 0.100 |
Why?
|
| Macrophages | 1 | 2015 | 439 | 0.100 |
Why?
|
| Serial Passage | 2 | 2024 | 5 | 0.100 |
Why?
|
| Species Specificity | 3 | 2017 | 245 | 0.100 |
Why?
|
| RNA | 1 | 2012 | 241 | 0.090 |
Why?
|
| Cytochromes b | 1 | 2009 | 6 | 0.090 |
Why?
|
| Antibodies, Neutralizing | 2 | 2024 | 109 | 0.090 |
Why?
|
| Electron Transport Complex III | 1 | 2009 | 13 | 0.090 |
Why?
|
| Epitopes | 2 | 2022 | 148 | 0.080 |
Why?
|
| Travel | 2 | 2019 | 32 | 0.080 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 191 | 0.080 |
Why?
|
| Retrospective Studies | 3 | 2020 | 2026 | 0.080 |
Why?
|
| Mitochondria | 1 | 2012 | 487 | 0.080 |
Why?
|
| Brazil | 2 | 2018 | 64 | 0.080 |
Why?
|
| Sierra Leone | 2 | 2019 | 3 | 0.080 |
Why?
|
| Female | 8 | 2018 | 20969 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2009 | 366 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 1371 | 0.070 |
Why?
|
| Bacterial Typing Techniques | 2 | 2017 | 34 | 0.070 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 93 | 0.070 |
Why?
|
| Virulence | 2 | 2017 | 223 | 0.070 |
Why?
|
| Adult | 5 | 2023 | 11712 | 0.070 |
Why?
|
| Recombination, Genetic | 2 | 2017 | 93 | 0.060 |
Why?
|
| Survival Analysis | 2 | 2015 | 325 | 0.060 |
Why?
|
| Receptors, CCR5 | 1 | 2024 | 61 | 0.060 |
Why?
|
| Male | 6 | 2018 | 20025 | 0.060 |
Why?
|
| Unsafe Sex | 2 | 2015 | 161 | 0.060 |
Why?
|
| Cell Line | 2 | 2017 | 1354 | 0.060 |
Why?
|
| Base Sequence | 2 | 2015 | 997 | 0.050 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2024 | 234 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2024 | 259 | 0.050 |
Why?
|
| Stress, Physiological | 2 | 2014 | 150 | 0.050 |
Why?
|
| Endonucleases | 1 | 2021 | 20 | 0.050 |
Why?
|
| Mutagenesis | 1 | 2021 | 89 | 0.050 |
Why?
|
| Mice | 3 | 2017 | 5913 | 0.050 |
Why?
|
| Buffaloes | 1 | 2020 | 3 | 0.050 |
Why?
|
| Costa Rica | 1 | 2020 | 7 | 0.050 |
Why?
|
| Population Dynamics | 1 | 2020 | 35 | 0.050 |
Why?
|
| Vaccination | 1 | 2022 | 288 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2024 | 1518 | 0.050 |
Why?
|
| Adolescent | 2 | 2023 | 5363 | 0.040 |
Why?
|
| West Indies | 1 | 2019 | 13 | 0.040 |
Why?
|
| Cuba | 1 | 2019 | 32 | 0.040 |
Why?
|
| Pacific Ocean | 1 | 2019 | 13 | 0.040 |
Why?
|
| Mosquito Control | 1 | 2019 | 14 | 0.040 |
Why?
|
| Democratic Republic of the Congo | 1 | 2019 | 5 | 0.040 |
Why?
|
| Genitalia, Male | 1 | 2018 | 13 | 0.040 |
Why?
|
| Contact Tracing | 1 | 2018 | 19 | 0.040 |
Why?
|
| Guinea | 1 | 2018 | 3 | 0.040 |
Why?
|
| Cattle | 1 | 2020 | 477 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2018 | 59 | 0.040 |
Why?
|
| Middle Aged | 3 | 2018 | 10129 | 0.040 |
Why?
|
| Emigration and Immigration | 1 | 2018 | 82 | 0.040 |
Why?
|
| Virus Activation | 1 | 2018 | 35 | 0.040 |
Why?
|
| Virus Cultivation | 1 | 2017 | 5 | 0.040 |
Why?
|
| Vesiculovirus | 1 | 2017 | 5 | 0.040 |
Why?
|
| Culex | 1 | 2017 | 3 | 0.040 |
Why?
|
| Adaptation, Biological | 1 | 2017 | 24 | 0.040 |
Why?
|
| Climate | 1 | 2017 | 14 | 0.040 |
Why?
|
| Ciprofloxacin | 1 | 2017 | 14 | 0.040 |
Why?
|
| Rec A Recombinases | 1 | 2017 | 2 | 0.040 |
Why?
|
| Burkholderia Infections | 1 | 2017 | 2 | 0.040 |
Why?
|
| Northern Territory | 1 | 2017 | 2 | 0.040 |
Why?
|
| Vero Cells | 1 | 2017 | 93 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2017 | 145 | 0.040 |
Why?
|
| Post-Exposure Prophylaxis | 1 | 2017 | 10 | 0.040 |
Why?
|
| Caribbean Region | 1 | 2017 | 69 | 0.040 |
Why?
|
| Internationality | 1 | 2017 | 32 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2017 | 87 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 132 | 0.040 |
Why?
|
| Point Mutation | 1 | 2017 | 93 | 0.040 |
Why?
|
| Melioidosis | 1 | 2017 | 21 | 0.040 |
Why?
|
| Australia | 1 | 2017 | 76 | 0.040 |
Why?
|
| False Positive Reactions | 1 | 2016 | 26 | 0.040 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 9 | 0.040 |
Why?
|
| Genes, Bacterial | 1 | 2017 | 90 | 0.040 |
Why?
|
| Water Microbiology | 1 | 2017 | 76 | 0.030 |
Why?
|
| Nigeria | 1 | 2016 | 86 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 171 | 0.030 |
Why?
|
| Dengue Virus | 1 | 2017 | 85 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2016 | 93 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2017 | 201 | 0.030 |
Why?
|
| Linear Models | 1 | 2017 | 275 | 0.030 |
Why?
|
| Arenavirus | 1 | 2015 | 1 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 186 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2015 | 20 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2016 | 142 | 0.030 |
Why?
|
| Coronavirus | 1 | 2015 | 7 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2017 | 127 | 0.030 |
Why?
|
| Giant Cells | 1 | 2015 | 13 | 0.030 |
Why?
|
| Nose Diseases | 1 | 2015 | 2 | 0.030 |
Why?
|
| Coitus | 1 | 2015 | 13 | 0.030 |
Why?
|
| Flavivirus | 1 | 2015 | 15 | 0.030 |
Why?
|
| Psychodidae | 1 | 2015 | 3 | 0.030 |
Why?
|
| Panama | 1 | 2015 | 5 | 0.030 |
Why?
|
| Florida | 1 | 2017 | 410 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2017 | 220 | 0.030 |
Why?
|
| Genes, Viral | 1 | 2015 | 63 | 0.030 |
Why?
|
| Prevalence | 1 | 2020 | 1455 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2016 | 106 | 0.030 |
Why?
|
| Drug Resistance, Viral | 1 | 2015 | 63 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 661 | 0.030 |
Why?
|
| Specimen Handling | 1 | 2015 | 56 | 0.030 |
Why?
|
| Cross Reactions | 1 | 2015 | 83 | 0.030 |
Why?
|
| Actins | 1 | 2015 | 148 | 0.030 |
Why?
|
| Infant | 1 | 2018 | 1046 | 0.030 |
Why?
|
| Immunity, Innate | 1 | 2015 | 149 | 0.030 |
Why?
|
| Cytokines | 1 | 2018 | 602 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2014 | 77 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2015 | 291 | 0.030 |
Why?
|
| RNA, Protozoan | 1 | 2014 | 13 | 0.030 |
Why?
|
| Genes, Protozoan | 1 | 2014 | 18 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 689 | 0.030 |
Why?
|
| Internet | 1 | 2015 | 211 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 515 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2018 | 1418 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 623 | 0.030 |
Why?
|
| Reassortant Viruses | 1 | 2013 | 10 | 0.030 |
Why?
|
| American Samoa | 1 | 2013 | 16 | 0.030 |
Why?
|
| Genes, MHC Class II | 1 | 2013 | 20 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2018 | 400 | 0.030 |
Why?
|
| Heat-Shock Response | 1 | 2013 | 19 | 0.030 |
Why?
|
| Algorithms | 1 | 2015 | 465 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 1180 | 0.030 |
Why?
|
| Protein Binding | 1 | 2015 | 972 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 2379 | 0.030 |
Why?
|
| Genome | 1 | 2013 | 125 | 0.030 |
Why?
|
| Cell Death | 1 | 2013 | 267 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 626 | 0.020 |
Why?
|
| Child | 1 | 2018 | 3131 | 0.020 |
Why?
|
| Aged | 1 | 2018 | 6741 | 0.020 |
Why?
|